M&A Overview And Outlook For Q4 2016

After the record breaking year that was 2015, MergerMarket's 2016 Half-Year Edition reports that M&A activity in the first half of 2016 has fallen by 10% in total deals and 30% in deal value compared to the same time last year. Despite this decline, 2016 should be looked upon favourably so far, considering the worldwide political instability it has faced with the United Kingdom's decision to leave the European Union (Brexit) and the uncertainty surrounding the United States Presidential election. Both of these events have contributed to a decrease in the volume and value of transactions in 2016. Further, this decline can be attributed in part to the megadeals that were abandoned in the first half of 2016. With the Allergan and Pfizer US$160bn deal, the Honeywell and United Technologies US$102bn deal and the Haliburton and Baker Hughes US$38bn deal all failing to close in the first half of 2016, this year was on track to be building upon 2015's success instead of failing